CD8A and neoplasm: Elevated PD-L1 expression on tumor cells facilitates the suppression of CD8+ T-cell activity and promotes the expansion of regulatory T cells (Tregs), thereby attenuating anti-tumor immunity and allowing unchecked cancer cell proliferation [32, 33].